Literature DB >> 8126161

An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion.

C D Malchoff1, G Reardon, D C MacGillivray, H Yamase, A D Rogol, D M Malchoff.   

Abstract

The McCune-Albright syndrome (MAS) is characterized clinically by polyostotic fibrous dysplasia, café-au-lait skin lesions, sexual precocity, and various other endocrinopathies. Recent investigations suggest an etiological role for embryonic somatic missense mutations that predict the substitution of a His or Cys for Arg at amino acid 201 of the Gs alpha-subunit (Gs alpha). Identification of these mutations in affected tissues is a sensitive assay that may help define a more complete clinical spectrum of the MAS. We investigated a woman who developed fibrous dysplasia 24 yr after premature menstruation. To determine if this was an unusual MAS variant, DNA and RNA were analyzed from affected and unaffected tissues. From samples of affected rib and normal rib DNA was extracted, amplified by polymerase chain reaction, subcloned, and sequenced. RNA was extracted from affected bone, reverse transcribed, amplified by polymerase chain reaction, subcloned, and sequenced. DNA sequence predicting a His for Arg substitution at Gs alpha amino acid 201 was found in 47% of the recombinant plasmids from DNA of affected bone and 17% of the plasmids from DNA of unaffected bone; a significant (P < 0.05) difference in frequency. The His201 substitution was found in 42% of the recombinant plasmids from RNA of affected bone. We conclude that this clinical variant is qualitatively indistinguishable from presentations of the complete MAS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126161     DOI: 10.1210/jcem.78.3.8126161

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.

Authors:  A Sakamoto; Y Oda; Y Iwamoto; M Tsuneyoshi
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

Review 2.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

3.  Gastrointestinal polyps in McCune Albright syndrome.

Authors:  Margaret Zacharin; Anurag Bajpai; Chung Wo Chow; Anthony Catto-Smith; Constantine Stratakis; Michelle W Wong; Rodney Scott
Journal:  J Med Genet       Date:  2011-02-28       Impact factor: 6.318

Review 4.  Fibrous dysplasia of bone: the bone lesion unmasked.

Authors:  F R Singer
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

5.  Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws.

Authors:  Milan M Patel; Jonathan F Wilkey; Rafik Abdelsayed; Nisha J D'Silva; Carl Malchoff; Sanjay M Mallya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-25

6.  Growth hormone-secreting pituitary adenoma associated with multiple bone cysts, skin pigmentation and aortitis syndrome.

Authors:  C Ihara; A Shimatsu; H Murabe; K Kataoka; C Kondo; K Nakao
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

7.  Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia.

Authors:  P J Marie; C de Pollak; P Chanson; A Lomri
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

8.  Primary hyperparathyroidism-associated polyostotic fibrous dysplasia: absence of McCune-Albright syndrome mutations.

Authors:  M M Hammami; A al-Zahrani; A Butt; L J Vencer; S S Hussain
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

9.  Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.

Authors:  Virginie Mariot; Joy Y Wu; Cumhur Aydin; Giovanna Mantovani; Matthew J Mahon; Agnès Linglart; Murat Bastepe
Journal:  Bone       Date:  2010-09-29       Impact factor: 4.398

10.  [Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome].

Authors:  J Pfeilschifter; R Ziegler
Journal:  Med Klin (Munich)       Date:  1998-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.